Clik here to view.
The Building Block Builders: The Digest’s 2016 8-Slide Guide to BioAmber
From the company’s IPO Prospectus: “Our proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into...
View ArticleClik here to view.
When amber means caution but BioAmber means go: progress, prospects for the...
In Canada, BioAmber recorded net income of $4.8M for Q2 2016 and an operating loss of $1.0M on revenues of $2.5M. Revenues were up 73 percent over Q1 and 637 percent compared to Q2 2015. For those less...
View ArticleClik here to view.
Scale-Up: What Makes the Winners Win?
News has arrived from Quebec and we are glad to report it that BioAmber, in its Sarnia succinic acid joint venture with Mitsui & Co., has achieved the final operational milestone set out in a $20...
View ArticleBioAmber seeing if Canada can match DOE’s loan guarantee to build next plant...
In Canada, BioAmber is deciding whether to set up a facility in Sarnia six-times bigger than its first installation in the city or to build the $500 million facility in Louisiana. The company has...
View ArticleBioAmber raises $7 million in share offering
In Quebec, BioAmber has priced an underwritten offering of 1,748,750 shares of its common stock at a price of $4.00 per share. The gross proceeds to the Company will be approximately $7.0 million, and...
View ArticleClik here to view.
BioAmber and the Charm of Making
If you remember the 1981 film Excalibur, there were numerous uses of what was described as the Charm of Making: Anál nathrach, orth’ bháis’s bethad, do chél dénmha Which roughly translates into Modern...
View ArticleClik here to view.
Scale-up, efficiency, available markets: The Digest’s 2017 Multi-Slide Guide...
BioAmber reported an unsurprisingly lackluster sales figure and a Q1 loss of $10.5M compared to a loss of $8.1M for Q1 2016 – unsurprising given the delays at major customer PTT. We covered the...
View ArticleClik here to view.
Psst! The latest bioeconomy flashes from Bayer, Gingko, BioAmber, Joule,...
While we’ve been busy fleeing Hurricane Irma, it’s been a busy week for the techies running the Digest’s Very Large Gossip Array — the airwaves have been crackling as some familiar faces re-surface....
View ArticleClik here to view.
Success in succinic, succinctly: The Digest’s 2017 Multi-Slide Guide to BioAmber
BioAmber’s Mission? To be a fast growing producer of chemical intermediates that uses sugars instead of fossil fuels and sells competitively priced, sustainable chemicals with strong profit margins and...
View ArticleBioAmber files for Chapter 11 in both US and Canada
In Canada, BioAmber Inc. announced that it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code and that its two Canadian subsidiaries, BioAmber Sarnia Inc. and...
View Article